Ever thought about outsourcing your next phase I trial overseas?

Then why not consider Belgium: short initiation timelines (for more info: click here), high scientific and medical quality, multilingual staff, large pool of volunteers, special populations and many other advantages.

With over 50 studies performed annually and more than 30 years in business, SGS is one of the European references for phase I studies (2 clinical centres - 90 beds - conducting first-in-man, C14-based ADME, special populations, PK/PD, interaction studies, QTc prolongation, BE/BA trials, proof-of-concept...…). Another focus is the analytical services, housed in our state-of-the-art labs (bioanalysis with 6 LC/MS-MS and high-throughput systems, radioisotopes lab, biomarker analysis - ask for our list of validated methods). Moreover, your projects can be managed out of our US offices in Germantown.

If you would like to find out more about SGS, or discuss your phase I or bioanalytical project with us, please visit us at booth n° 588 at the AAPS Annual Meeting - and ask for Dr. Rudi Segers or McKenzie Clement, they will be glad to answer your questions.

If you would like to receive some more info, please do not hesitate to contact us:

Dries De Pauw
Global Business Manager Clinical Research
HQ tel: +32.15.27.32.45
HQ fax: +32.15.27.32.50
Mobile phone: +32.475 80.11.71
e-mail: dries.de.pauw@sgs.com
Web: http://www.sgs.com/lifescience